<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38137059</PMID><DateRevised><Year>2023</Year><Month>12</Month><Day>25</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2076-3425</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>12</Issue><PubDate><Year>2023</Year><Month>Nov</Month><Day>21</Day></PubDate></JournalIssue><Title>Brain sciences</Title><ISOAbbreviation>Brain Sci</ISOAbbreviation></Journal><ArticleTitle>Post-COVID-19 Cognitive Decline and Apoe Polymorphism: Towards a Possible Link?</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1611</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/brainsci13121611</ELocationID><Abstract><AbstractText><i>APOE</i> &#x3b5;4 polymorphism has been recently described as a possible association with cognitive deficits in COVID-19 patients. This research aimed to establish the correlation between COVID-19 and cognitive impairment, and the <i>APOE</i> gene polymorphism among outpatients. We performed a cross-sectional study with confirmed COVID-19 patients and neurological symptoms that persisted for more than three months from onset. <i>APOE</i> genotypes were determined. The final number of patients included in this study was 219, of which 186 blood samples were collected for <i>APOE</i> genotyping, evaluated 4.5 months after COVID-19. Among the participants, 143 patients (65.3%) reported memory impairment symptoms as their primary concern. However, this complaint was objectively verified through screening tests (Addenbrooke Cognitive Examination-Revised and Mini-Mental State Examination) in only 36 patients (16.4%). The group experiencing cognitive decline exhibited a higher prevalence of the <i>APOE</i> &#x3b5;4 allele than the normal group (30.8% vs. 16.4%, respectively, <i>p</i> = 0.038). Furthermore, <i>the APOE</i> &#x3b5;4 allele and anxiety symptoms remained significant after multivariate analysis. This study assessed an outpatient population where cognitive changes were the primary complaint, even in mild cases. Moreover, the &#x3b5;4 allele, sleep disorders, and anxiety symptoms were more frequent in the cognitive decline group.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tavares-J&#xfa;nior</LastName><ForeName>Jos&#xe9; Wagner Leonel</ForeName><Initials>JWL</Initials><AffiliationInfo><Affiliation>Neurology Division, Clinical Medicine Department, Faculty of Medicine, Federal University of Cear&#xe1; (UFC), Fortaleza 60020-181, CE, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Research Unit, Walter Cantidio University Hospital, Federal University of Cear&#xe1; (UFC), Fortaleza 60020-181, CE, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oliveira</LastName><ForeName>Danilo Nunes</ForeName><Initials>DN</Initials><AffiliationInfo><Affiliation>Neurology Division, Clinical Medicine Department, Faculty of Medicine, Federal University of Cear&#xe1; (UFC), Fortaleza 60020-181, CE, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Research Unit, Walter Cantidio University Hospital, Federal University of Cear&#xe1; (UFC), Fortaleza 60020-181, CE, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>da Silva</LastName><ForeName>Jean Breno Silveira</ForeName><Initials>JBS</Initials><AffiliationInfo><Affiliation>Medicine Research and Development Center (NPDM), Pharmacogenetics Laboratory, Federal University of Cear&#xe1; (UFC), Fortaleza 60020-181, CE, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Queiroz Feitosa</LastName><ForeName>Werbety Lucas</ForeName><Initials>WL</Initials><Identifier Source="ORCID">0000-0003-1154-257X</Identifier><AffiliationInfo><Affiliation>Neurology Division, Clinical Medicine Department, Faculty of Medicine, Federal University of Cear&#xe1; (UFC), Fortaleza 60020-181, CE, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Research Unit, Walter Cantidio University Hospital, Federal University of Cear&#xe1; (UFC), Fortaleza 60020-181, CE, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sousa</LastName><ForeName>Artur Victor Menezes</ForeName><Initials>AVM</Initials><AffiliationInfo><Affiliation>Neurology Division, Clinical Medicine Department, Faculty of Medicine, Federal University of Cear&#xe1; (UFC), Fortaleza 60020-181, CE, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marinho</LastName><ForeName>Samuel Cavalcante</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>Health Sciences Center, State University of Cear&#xe1; (UECE), Fortaleza 60714-903, CE, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cunha</LastName><ForeName>Let&#xed;cia Chaves Vieira</ForeName><Initials>LCV</Initials><AffiliationInfo><Affiliation>Neurology Division, Clinical Medicine Department, Faculty of Medicine, Federal University of Cear&#xe1; (UFC), Fortaleza 60020-181, CE, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Research Unit, Walter Cantidio University Hospital, Federal University of Cear&#xe1; (UFC), Fortaleza 60020-181, CE, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gaspar</LastName><ForeName>Safira de Brito</ForeName><Initials>SB</Initials><AffiliationInfo><Affiliation>Health Sciences Center, State University of Cear&#xe1; (UECE), Fortaleza 60714-903, CE, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gomes</LastName><ForeName>Carmem Meyve Pereira</ForeName><Initials>CMP</Initials><AffiliationInfo><Affiliation>Health Sciences Center, State University of Cear&#xe1; (UECE), Fortaleza 60714-903, CE, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Oliveira</LastName><ForeName>La&#xed;s Lacerda Brasil</ForeName><Initials>LLB</Initials><AffiliationInfo><Affiliation>Medicine Research and Development Center (NPDM), Pharmacogenetics Laboratory, Federal University of Cear&#xe1; (UFC), Fortaleza 60020-181, CE, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moreira-Nunes</LastName><ForeName>Caroline Aquino</ForeName><Initials>CA</Initials><Identifier Source="ORCID">0000-0001-5845-3481</Identifier><AffiliationInfo><Affiliation>Medicine Research and Development Center (NPDM), Pharmacogenetics Laboratory, Federal University of Cear&#xe1; (UFC), Fortaleza 60020-181, CE, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sobreira</LastName><ForeName>Emmanuelle Silva Tavares</ForeName><Initials>EST</Initials><AffiliationInfo><Affiliation>Neurology Division, Clinical Medicine Department, Faculty of Medicine, Federal University of Cear&#xe1; (UFC), Fortaleza 60020-181, CE, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Research Unit, Walter Cantidio University Hospital, Federal University of Cear&#xe1; (UFC), Fortaleza 60020-181, CE, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moraes</LastName><ForeName>Maria Elisabete Amaral de</ForeName><Initials>MEA</Initials><AffiliationInfo><Affiliation>Medicine Research and Development Center (NPDM), Pharmacogenetics Laboratory, Federal University of Cear&#xe1; (UFC), Fortaleza 60020-181, CE, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sobreira-Neto</LastName><ForeName>Manoel Alves</ForeName><Initials>MA</Initials><Identifier Source="ORCID">0000-0001-9619-6551</Identifier><AffiliationInfo><Affiliation>Neurology Division, Clinical Medicine Department, Faculty of Medicine, Federal University of Cear&#xe1; (UFC), Fortaleza 60020-181, CE, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Research Unit, Walter Cantidio University Hospital, Federal University of Cear&#xe1; (UFC), Fortaleza 60020-181, CE, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Montenegro</LastName><ForeName>Raquel Carvalho</ForeName><Initials>RC</Initials><AffiliationInfo><Affiliation>Medicine Research and Development Center (NPDM), Pharmacogenetics Laboratory, Federal University of Cear&#xe1; (UFC), Fortaleza 60020-181, CE, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Braga-Neto</LastName><ForeName>Pedro</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0001-9186-9243</Identifier><AffiliationInfo><Affiliation>Neurology Division, Clinical Medicine Department, Faculty of Medicine, Federal University of Cear&#xe1; (UFC), Fortaleza 60020-181, CE, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Research Unit, Walter Cantidio University Hospital, Federal University of Cear&#xe1; (UFC), Fortaleza 60020-181, CE, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Health Sciences Center, State University of Cear&#xe1; (UECE), Fortaleza 60714-903, CE, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>409123/2022-6</GrantID><Agency>National Council for Scientific and Technological Development</Agency><Country/></Grant><Grant><GrantID>88881.505364/2020-01a</GrantID><Agency>Coordena&#xe7;&#xe3;o de Aperfeicoamento de Pessoal de N&#xed;vel Superior</Agency><Country/></Grant><Grant><Agency>Funda&#xe7;&#xe3;o Cearense de Apoio ao Desenvolvimento Cient&#xed;fico e Tecnol&#xf3;gico</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>11</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Brain Sci</MedlineTA><NlmUniqueID>101598646</NlmUniqueID><ISSNLinking>2076-3425</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">APOE</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">cognitive impairment</Keyword><Keyword MajorTopicYN="N">dementia</Keyword><Keyword MajorTopicYN="N">long-COVID</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>10</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>11</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>11</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>12</Month><Day>23</Day><Hour>12</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>12</Month><Day>23</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>12</Month><Day>23</Day><Hour>1</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>11</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38137059</ArticleId><ArticleId IdType="pmc">PMC10742128</ArticleId><ArticleId IdType="doi">10.3390/brainsci13121611</ArticleId><ArticleId IdType="pii">brainsci13121611</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mao L., Jin H., Wang M., Hu Y., Chen S., He Q., Chang J., Hong C., Zhou Y., Wang D., et al. Neurologic Manifestations of Hospitalized Patients with Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol. 2020;77:683&#x2013;690. doi: 10.1001/jamaneurol.2020.1127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2020.1127</ArticleId><ArticleId IdType="pmc">PMC7149362</ArticleId><ArticleId IdType="pubmed">32275288</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou H., Lu S., Chen J., Wei N., Wang D., Lyu H., Shi C., Hu S. The landscape of cognitive function in recovered COVID-19 patients. J. Psychiatr. Res. 2020;129:98&#x2013;102. doi: 10.1016/j.jpsychires.2020.06.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychires.2020.06.022</ArticleId><ArticleId IdType="pmc">PMC7324344</ArticleId><ArticleId IdType="pubmed">32912598</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Brutto O.H., Wu S., Mera R., Costa A., Recalde B., Issa N. Cognitive decline among individuals with history of mild symptomatic SARS-CoV-2 infection: A longitudinal prospective study nested to a population cohort. Eur. J. Neurol. 2021;28:3245&#x2013;3253. doi: 10.1111/ene.14775.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14775</ArticleId><ArticleId IdType="pmc">PMC8014083</ArticleId><ArticleId IdType="pubmed">33576150</ArticleId></ArticleIdList></Reference><Reference><Citation>Nath A. Long-Haul COVID. Neurology. 2020;95:559&#x2013;560. doi: 10.1212/WNL.0000000000010640.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000010640</ArticleId><ArticleId IdType="pubmed">32788251</ArticleId></ArticleIdList></Reference><Reference><Citation>Espinosa-Salinas I., Colmenarejo G., Fern&#xe1;ndez-D&#xed;az C., G&#xf3;mez de Cedr&#xf3;n M., Martinez J., Reglero G., Ram&#xed;rez de Molina A. Potential protective effect against SARS-CoV-2 infection by APOE rs7412 polymorphism. Sci. Rep. 2022;12:7247. doi: 10.1038/s41598-022-10923-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-10923-4</ArticleId><ArticleId IdType="pmc">PMC9065660</ArticleId><ArticleId IdType="pubmed">35508522</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo C.L., Pilling L.C., Atkins J.L., Masoli J.A.H., Delgado J., Kuchel G.A., Melzer D. APOE e4 genotype predicts severe COVID-19 in the UK biobank community cohort. J. Gerontol.-Ser. A Biol. Sci. Med. Sci. 2020;75:2231&#x2013;2232. doi: 10.1093/gerona/glaa131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/gerona/glaa131</ArticleId><ArticleId IdType="pmc">PMC7314139</ArticleId><ArticleId IdType="pubmed">32451547</ArticleId></ArticleIdList></Reference><Reference><Citation>Poirier J., Bertrand P., Kogan S., Gauthier S., Davignon J., Bouthillier D. Apolipoprotein E polymorphism and Alzheimer&#x2019;s disease. Lancet. 1993;342:697&#x2013;699. doi: 10.1016/0140-6736(93)91705-Q.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0140-6736(93)91705-Q</ArticleId><ArticleId IdType="pubmed">8103819</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H., Shao L., Lin Z., Long Q.X., Yuan H., Cai L., Jiang G., Guo X., Yang R., Zhang Z., et al. APOE interacts with ACE2 inhibiting SARS-CoV-2 cellular entry and inflammation in COVID-19 patients. Signal Transduct. Target. Ther. 2022;7:261. doi: 10.1038/s41392-022-01118-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-022-01118-4</ArticleId><ArticleId IdType="pmc">PMC9340718</ArticleId><ArticleId IdType="pubmed">35915083</ArticleId></ArticleIdList></Reference><Reference><Citation>Zorkina Y., Syunyakov T., Abramova O., Andryushchenko A., Andreuyk D., Abbazova E., Goncharov D., Rakova A., Andriushchenko N., Gryadunov D., et al. Positive Effect of Cognitive Training in Older Adults with Different APOE Genotypes and COVID-19 History: A 1-Year Follow-Up Cohort Study. Diagnostics. 2022;12:2312. doi: 10.3390/diagnostics12102312.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics12102312</ArticleId><ArticleId IdType="pmc">PMC9600912</ArticleId><ArticleId IdType="pubmed">36292001</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Battista A.M., Heinsinger N.M., Rebeck G.W. Alzheimer&#x2019;s Disease Genetic Risk Factor APOE-&#x3b5;4 Also Affects Normal Brain Function. Curr. Alzheimer Res. 2016;13:1200&#x2013;1207. doi: 10.2174/1567205013666160401115127.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1567205013666160401115127</ArticleId><ArticleId IdType="pmc">PMC5839141</ArticleId><ArticleId IdType="pubmed">27033053</ArticleId></ArticleIdList></Reference><Reference><Citation>Tavares-J&#xfa;nior J.W.L. Long-covid cognitive impairment: Cognitive assessment and apolipoprotein E (APOE) genotyping correlation in a Brazilian cohort. Front. Psychiatry. 2022;13:947583. doi: 10.3389/fpsyt.2022.947583.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2022.947583</ArticleId><ArticleId IdType="pmc">PMC9423011</ArticleId><ArticleId IdType="pubmed">36046159</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen F., Chen Y., Wang Y., Ke Q., Cui L. The COVID-19 pandemic and Alzheimer&#x2019;s disease: Mutual risks and mechanisms. Transl. Neurodegener. 2022;11:40. doi: 10.1186/s40035-022-00316-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40035-022-00316-y</ArticleId><ArticleId IdType="pmc">PMC9464468</ArticleId><ArticleId IdType="pubmed">36089575</ArticleId></ArticleIdList></Reference><Reference><Citation>Jessen F., Amariglio R.E., van Boxtel M., Breteler M., Ceccaldi M., Ch&#xe9;telat G., Dubois B., Dufouil C., Ellis K.A., van der Flier W.M., et al. A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer&#x2019;s disease. Alzheimer&#x2019;s Dement. 2014;10:844&#x2013;852. doi: 10.1016/j.jalz.2014.01.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2014.01.001</ArticleId><ArticleId IdType="pmc">PMC4317324</ArticleId><ArticleId IdType="pubmed">24798886</ArticleId></ArticleIdList></Reference><Reference><Citation>Scientific T.F. SNP APOE, C___3084793_20.  [(accessed on 4 August 2022)].  Available online:  https://www.bioz.com/result/snp.</Citation></Reference><Reference><Citation>Akritas M.G. Book Review: Nonparametric statistical methods, 2nd edition. Stat. Methods Med. Res. 1999;8:331&#x2013;332. doi: 10.1177/096228029900800405.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/096228029900800405</ArticleId></ArticleIdList></Reference><Reference><Citation>Jay C.W. Practical Nonparametric Statistics. 3rd ed. John Wiley &amp; Sons; New York, NY, USA: 1999.</Citation></Reference><Reference><Citation>Moura A.E.F., Oliveira D.N., Torres D.M., Tavares-J&#xfa;nior J.W.L., N&#xf3;brega P.R., Braga-Neto P., Sobreira-Neto M.A. Central hypersomnia and chronic insomnia: Expanding the spectrum of sleep disorders in long COVID syndrome&#x2014;A prospective cohort study. BMC Neurol. 2022;22:417. doi: 10.1186/s12883-022-02940-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12883-022-02940-7</ArticleId><ArticleId IdType="pmc">PMC9643986</ArticleId><ArticleId IdType="pubmed">36352367</ArticleId></ArticleIdList></Reference><Reference><Citation>Varga Z., Flammer A.J., Steiger P., Haberecker M., Andermatt R., Zinkernagel A.S., Mehra M.R., Schuepbach R.A., Ruschitzka F., Moch H. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395:1417&#x2013;1418. doi: 10.1016/S0140-6736(20)30937-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30937-5</ArticleId><ArticleId IdType="pmc">PMC7172722</ArticleId><ArticleId IdType="pubmed">32325026</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon I.H., Normandin E., Bhattacharyya S., Mukerji S.S., Keller K., Ali A.S., Adams G., Hornick J.L., Padera R.F., Jr., Sabeti P. Neuropathological Features of COVID-19. N. Engl. J. Med. 2020;383:989&#x2013;992. doi: 10.1056/NEJMc2019373.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2019373</ArticleId><ArticleId IdType="pmc">PMC7304421</ArticleId><ArticleId IdType="pubmed">32530583</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandrekar S., Landreth G.E. Microglia and Inflammation in Alzheimer&#x2019;s Disease. CNS Neurol. Disord.-Drug Targets (Former. Curr. Drug Targets-CNS Neurol. Disord.) 2010;9:156&#x2013;167.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3653290</ArticleId><ArticleId IdType="pubmed">20205644</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y.W.A., Zhou B., Wernig M., S&#xfc;dhof T.C. ApoE2, ApoE3, and ApoE4 Differentially Stimulate APP Transcription and A&#x3b2; Secretion. Cell. 2017;168:427&#x2013;441.e21. doi: 10.1016/j.cell.2016.12.044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2016.12.044</ArticleId><ArticleId IdType="pmc">PMC5310835</ArticleId><ArticleId IdType="pubmed">28111074</ArticleId></ArticleIdList></Reference><Reference><Citation>Crunfli F., Carregari V.C., Veras F.P., Silva L.S., Nogueira M.H., Antunes A.S.L.M., Vendramini P.H., Valen&#xe7;a A.G.F., Brand&#xe3;o-Teles C., Zuccoli G.D., et al. Morphological, cellular, and molecular basis of brain infection in COVID-19 patients. Proc. Natl. Acad. Sci. USA. 2022;119:e2200960119. doi: 10.1073/pnas.2200960119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2200960119</ArticleId><ArticleId IdType="pmc">PMC9436354</ArticleId><ArticleId IdType="pubmed">35951647</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S., Devanney N.A., Golden L.R., Smith C.T., Schwartz J.L., Walsh A.E., Clarke H.A., Goulding D.S., Allenger E.J., Morillo-Segovia G., et al. APOE modulates microglial immunometabolism in response to age, amyloid pathology, and inflammatory challenge. Cell Rep. 2023;42:112196. doi: 10.1016/j.celrep.2023.112196.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2023.112196</ArticleId><ArticleId IdType="pmc">PMC10117631</ArticleId><ArticleId IdType="pubmed">36871219</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramani A., M&#xfc;ller L., Ostermann P.N., Gabriel E., Abida-Islam P., M&#xfc;ller-Schiffmann A., Mariappan A., Goureau O., Gruell H., Walker A., et al. SARS-CoV-2 targets neurons of 3D human brain organoids. EMBO J. 2020;39:e106230. doi: 10.15252/embj.2020106230.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.2020106230</ArticleId><ArticleId IdType="pmc">PMC7560208</ArticleId><ArticleId IdType="pubmed">32876341</ArticleId></ArticleIdList></Reference><Reference><Citation>Segev Y., Michaelson D.M., Rosenblum K. ApoE &#x3b5;4 is associated with eIF2&#x3b1; phosphorylation and impaired learning in young mice. Neurobiol. Aging. 2013;34:863&#x2013;872. doi: 10.1016/j.neurobiolaging.2012.06.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2012.06.020</ArticleId><ArticleId IdType="pubmed">22883908</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen F., Chen Y., Ke Q., Wang Y., Gong Z., Chen X., Cai Y., Li S., Sun Y., Peng X., et al. ApoE4 associated with severe COVID-19 outcomes via downregulation of ACE2 and imbalanced RAS pathway. J. Transl. Med. 2023;21:103. doi: 10.1186/s12967-023-03945-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-023-03945-7</ArticleId><ArticleId IdType="pmc">PMC9910247</ArticleId><ArticleId IdType="pubmed">36759834</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C., Arendt-Nielsen L., D&#xed;az-Gil G., G&#xf3;mez-Esquer F., Gil-Crujera A., G&#xf3;mez-S&#xe1;nchez S.M., Ambite-Quesada S., Palomar-Gallego M.A., Pellicer-Valero O.J., Giordano R. Apolipoprotein E (ApoE) &#x3b5;4 Genotype (ApoE rs429358&#x2014;ApoE rs7412 Polymorphisms) Is Not Associated with Long COVID Symptoms in Previously Hospitalized COVID-19 Survivors. Genes. 2023;14:1420. doi: 10.3390/genes14071420.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/genes14071420</ArticleId><ArticleId IdType="pmc">PMC10379077</ArticleId><ArticleId IdType="pubmed">37510324</ArticleId></ArticleIdList></Reference><Reference><Citation>Khanna S., Khanna N., Malav M.K., Bayad H.C., Sood A., Abraham L. Profiling cognitive impairment in mild COVID-19 patients: A case-control study at a secondary healthcare centre in the hilly region of North India. Ann. Indian. Acad. Neurol. 2022;25:1099&#x2013;1103.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9996485</ArticleId><ArticleId IdType="pubmed">36911430</ArticleId></ArticleIdList></Reference><Reference><Citation>Rass V., Beer R., Schiefecker A.J., Lindner A., Kofler M., Ianosi B.A., Mahlknecht P., Heim B., Peball M., Carbone F., et al. Neurological outcomes 1 year after COVID-19 diagnosis: A prospective longitudinal cohort study. Eur. J. Neurol. 2022;29:1685&#x2013;1696. doi: 10.1111/ene.15307.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.15307</ArticleId><ArticleId IdType="pmc">PMC9111823</ArticleId><ArticleId IdType="pubmed">35239247</ArticleId></ArticleIdList></Reference><Reference><Citation>Lynch S., Ferrando S.J., Dornbush R., Shahar S., Smiley A., Klepacz L. Screening for brain fog: Is the Montreal cognitive assessment an effective screening tool for neurocognitive complaints post-COVID-19? Gen. Hosp. Psychiatry. 2022;78:80&#x2013;86. doi: 10.1016/j.genhosppsych.2022.07.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.genhosppsych.2022.07.013</ArticleId><ArticleId IdType="pmc">PMC9359801</ArticleId><ArticleId IdType="pubmed">35930974</ArticleId></ArticleIdList></Reference><Reference><Citation>Mesulam M.-M. Principles of Behavioral and Cognitive Neurology. 2nd ed. Oxford University Press; Oxford, UK: 2000.</Citation></Reference><Reference><Citation>Delgado-Alonso C., Valles-Salgado M., Delgado-&#xc1;lvarez A., Yus M., G&#xf3;mez-Ruiz N., Jorquera M., Polidura C., Gil M.J., Marcos A., Mat&#xed;as-Guiu J., et al. Cognitive dysfunction associated with COVID-19: A comprehensive neuropsychological study. J. Psychiatr. Res. 2022;150:40&#x2013;46. doi: 10.1016/j.jpsychires.2022.03.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychires.2022.03.033</ArticleId><ArticleId IdType="pmc">PMC8943429</ArticleId><ArticleId IdType="pubmed">35349797</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a-S&#xe1;nchez C., Calabria M., Grunden N., Pons C., Arroyo J.A., G&#xf3;mez-Anson B., Lle&#xf3; A., Alcolea D., Belv&#xed;s R., Moroll&#xf3;n N., et al. Neuropsychological deficits in patients with cognitive complaints after COVID-19. Brain Behav. 2022;12:e2508. doi: 10.1002/brb3.2508.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/brb3.2508</ArticleId><ArticleId IdType="pmc">PMC8933779</ArticleId><ArticleId IdType="pubmed">35137561</ArticleId></ArticleIdList></Reference><Reference><Citation>Puchner B., Sahanic S., Kirchmair R., Pizzini A., Sonnweber B., W&#xf6;ll E., M&#xfc;hlbacher A., Garimorth K., Dareb B., Ehling R., et al. Beneficial effects of multi-disciplinary rehabilitation in postacute COVID-19: An observational cohort study. Eur. J. Phys. Rehabil. Med. 2021;57:189&#x2013;198. doi: 10.23736/S1973-9087.21.06549-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.23736/S1973-9087.21.06549-7</ArticleId><ArticleId IdType="pubmed">33448756</ArticleId></ArticleIdList></Reference><Reference><Citation>Raz N., Rodrigue K.M. Differential aging of the brain: Patterns, cognitive correlates and modifiers. Neurosci. Biobehav. Rev. 2006;30:730&#x2013;748. doi: 10.1016/j.neubiorev.2006.07.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neubiorev.2006.07.001</ArticleId><ArticleId IdType="pmc">PMC6601348</ArticleId><ArticleId IdType="pubmed">16919333</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw K., Bell L., Boyd K., Grijseels D.M., Clarke D., Bonnar O., Crombag H.S., Hall C.N. Neurovascular coupling and oxygenation are decreased in hippocampus compared to neocortex because of microvascular differences. Nat. Commun. 2021;12:3190. doi: 10.1038/s41467-021-23508-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-23508-y</ArticleId><ArticleId IdType="pmc">PMC8160329</ArticleId><ArticleId IdType="pubmed">34045465</ArticleId></ArticleIdList></Reference><Reference><Citation>Sartori A.C., Vance D.E., Slater L.Z., Crowe M. The impact of inflammation on cognitive function in older adults: Implications for healthcare practice and research. J. Neurosci. Nurs. 2012;44:206&#x2013;217. doi: 10.1097/JNN.0b013e3182527690.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/JNN.0b013e3182527690</ArticleId><ArticleId IdType="pmc">PMC3390758</ArticleId><ArticleId IdType="pubmed">22743812</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosp J.A., Dressing A., Blazhenets G., Bormann T., Rau A., Schwabenland M., Thurow J., Wagner D., Waller C., Niesen W.D., et al. Cognitive impairment and altered cerebral glucose metabolism in the subacute stage of COVID-19. Brain. 2021;144:1263&#x2013;1276. doi: 10.1093/brain/awab009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awab009</ArticleId><ArticleId IdType="pmc">PMC8083602</ArticleId><ArticleId IdType="pubmed">33822001</ArticleId></ArticleIdList></Reference><Reference><Citation>Hugon J., Msika E.F., Queneau M., Farid K., Paquet C. Long COVID: Cognitive complaints (brain fog) and dysfunction of the cingulate cortex. J. Neurol. 2022;269:44&#x2013;46. doi: 10.1007/s00415-021-10655-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-021-10655-x</ArticleId><ArticleId IdType="pmc">PMC8211714</ArticleId><ArticleId IdType="pubmed">34143277</ArticleId></ArticleIdList></Reference><Reference><Citation>Hugon J., Queneau M., Sanchez Ortiz M., Msika E.F., Farid K., Paquet C. Cognitive decline and brainstem hypometabolism in long COVID: A case series. Brain Behav. 2022;12:e2513. doi: 10.1002/brb3.2513.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/brb3.2513</ArticleId><ArticleId IdType="pmc">PMC9014998</ArticleId><ArticleId IdType="pubmed">35290729</ArticleId></ArticleIdList></Reference><Reference><Citation>Miskowiak K.W., Johnsen S., Sattler S.M., Nielsen S., Kunalan K., Rungby J., Lapperre T., Porsberg C.M. Cognitive impairments four months after COVID-19 hospital discharge: Pattern, severity and association with illness variables. Eur. Neuropsychopharmacol. 2021;46:39&#x2013;48. doi: 10.1016/j.euroneuro.2021.03.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.euroneuro.2021.03.019</ArticleId><ArticleId IdType="pmc">PMC8006192</ArticleId><ArticleId IdType="pubmed">33823427</ArticleId></ArticleIdList></Reference><Reference><Citation>Cristillo V., Pilotto A., Cotti Piccinelli S., Zoppi N., Bonzi G., Gipponi S., Sattin D., Schiavolin S., Raggi A., Bezzi M., et al. Age and subtle cognitive impairment are associated with long-term olfactory dysfunction after COVID-19 infection. J. Am. Geriatr. Soc. 2021;69:2778&#x2013;2780. doi: 10.1111/jgs.17296.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.17296</ArticleId><ArticleId IdType="pmc">PMC8242714</ArticleId><ArticleId IdType="pubmed">34019707</ArticleId></ArticleIdList></Reference><Reference><Citation>Martelletti P., Bentivegna E., Spuntarelli V., Luciani M. Long-COVID Headache. SN Compr. Clin. Med. 2021;3:1704&#x2013;1706. doi: 10.1007/s42399-021-00964-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s42399-021-00964-7</ArticleId><ArticleId IdType="pmc">PMC8136258</ArticleId><ArticleId IdType="pubmed">34036244</ArticleId></ArticleIdList></Reference><Reference><Citation>Ownby R.L., Crocco E., Acevedo A., John V., Loewenstein D. Depression and risk for Alzheimer disease: Systematic review, meta-analysis, and metaregression analysis. Arch. Gen. Psychiatry. 2006;63:530&#x2013;538. doi: 10.1001/archpsyc.63.5.530.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archpsyc.63.5.530</ArticleId><ArticleId IdType="pmc">PMC3530614</ArticleId><ArticleId IdType="pubmed">16651510</ArticleId></ArticleIdList></Reference><Reference><Citation>Ismael F., Bizario J.C.S., Battagin T., Zaramella B., Leal F.E., Torales J., Ventriglio A., Marziali M.E., Martins S.S., Castaldelli-Maia J.M. Post-infection depressive, anxiety and post-traumatic stress symptoms: A prospective cohort study in patients with mild COVID-19. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2021;111:110341. doi: 10.1016/j.pnpbp.2021.110341.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pnpbp.2021.110341</ArticleId><ArticleId IdType="pmc">PMC8086265</ArticleId><ArticleId IdType="pubmed">33940097</ArticleId></ArticleIdList></Reference><Reference><Citation>Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic. Lancet. 2021;398:1700&#x2013;1712. doi: 10.1016/S0140-6736(21)02143-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)02143-7</ArticleId><ArticleId IdType="pmc">PMC8500697</ArticleId><ArticleId IdType="pubmed">34634250</ArticleId></ArticleIdList></Reference><Reference><Citation>Dehaene S., Cohen L., Morais J., Kolinsky R. Illiterate to literate: Behavioural and cerebral changes induced by reading acquisition. Nat. Rev. Neurosci. 2015;16:234&#x2013;244. doi: 10.1038/nrn3924.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn3924</ArticleId><ArticleId IdType="pubmed">25783611</ArticleId></ArticleIdList></Reference><Reference><Citation>Abramova O., Zorkina Y., Ushakova V., Gryadunov D., Ikonnikova A., Fedoseeva E., Emelyanova M., Ochneva A., Morozova I., Pavlov K., et al. Alteration of Blood Immune Biomarkers in MCI Patients with Different APOE Genotypes after Cognitive Training: A 1 Year Follow-Up Cohort Study. Int. J. Mol. Sci. 2023;24:13395. doi: 10.3390/ijms241713395.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms241713395</ArticleId><ArticleId IdType="pmc">PMC10488004</ArticleId><ArticleId IdType="pubmed">37686198</ArticleId></ArticleIdList></Reference><Reference><Citation>Mioshi E., Dawson K., Mitchell J., Arnold R., Hodges J.R. The Addenbrooke&#x2019;s Cognitive Examination Revised (ACE-R): A brief cognitive test battery for dementia screening. Int. J. Geriatr. Psychiatry J. Psychiatry Late Life Allied Sci. 2006;21:1078&#x2013;1085. doi: 10.1002/gps.1610.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gps.1610</ArticleId><ArticleId IdType="pubmed">16977673</ArticleId></ArticleIdList></Reference><Reference><Citation>Folstein M.F., Folstein S.E., McHugh P.R. Mini-mental state&#x2019;: A practical method for grading the cognitive state of patients for the clinician. J. Psychiatry Res. 1975;12:189&#x2013;198. doi: 10.1016/0022-3956(75)90026-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-3956(75)90026-6</ArticleId><ArticleId IdType="pubmed">1202204</ArticleId></ArticleIdList></Reference><Reference><Citation>Hughes C.P., Berg L., Danziger W.L., Coben L.A., Martin R.L. A new clinical scale for the staging of dementia. Br. J. Psychiatry. 1982;140:566&#x2013;572. doi: 10.1192/bjp.140.6.566.</Citation><ArticleIdList><ArticleId IdType="doi">10.1192/bjp.140.6.566</ArticleId><ArticleId IdType="pubmed">7104545</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfeffer R.I., Kurosaki T.T., Harrah C.H., Jr., Chance J.M., Filos S. Measurement of functional activities in older adults in the community. J. Gerontol. 1982;37:323&#x2013;329. doi: 10.1093/geronj/37.3.323.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geronj/37.3.323</ArticleId><ArticleId IdType="pubmed">7069156</ArticleId></ArticleIdList></Reference><Reference><Citation>Yesavage J.A., Brink T.L., Rose T.L., Lum O., Huang V., Adey M., Leirer V.O. Development and validation of a geriatric depression screening scale: A preliminary report. J. Psychiatr. Res. 1982;17:37&#x2013;49. doi: 10.1016/0022-3956(82)90033-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-3956(82)90033-4</ArticleId><ArticleId IdType="pubmed">7183759</ArticleId></ArticleIdList></Reference><Reference><Citation>Beck A.T., Steer R.A. Beck Depression Inventory Manual. Psychological Corporation, San Antonio. References-Scientific Research Publishing. 1993.  [(accessed on 2 September 2020)].  Available online:  https://www.scirp.org/(S(vtj3fa45qm1ean45vvffcz55))/reference/ReferencesPapers.aspx?ReferenceID=1927212&gt;.</Citation></Reference><Reference><Citation>Benites D., Gomes W.B. The Prospective and Retrospective Memory Questionnaire&#x2019;s (PRMQ) translation, adaptation and preliminary validation. Psico-USF. 2007;12:45&#x2013;54. doi: 10.1590/S1413-82712007000100006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/S1413-82712007000100006</ArticleId></ArticleIdList></Reference><Reference><Citation>Tavares-J&#xfa;nior J.W.L. Master&#x2019;s Thesis. Faculdade de Medicina, Universidade Federal do Cear&#xe1;; Fortaleza, Brazil: 2020. Avalia&#xe7;&#xe3;o da Acur&#xe1;cia da Escala de Addenbrooke como Instrumento de Rastreio Cognitivo de Pacientes Idosos com Baixa Escolaridade.</Citation></Reference><Reference><Citation>C&#xe9;sar K.G., Yassuda M.S., Porto F.H.G., Brucki S.M.D., Nitrini R. Addenbrooke&#x2019;s cognitive examination-revised: Normative and accuracy data for seniors with heterogeneous educational level in Brazil. Int. Psychogeriatr. 2017;29:1345&#x2013;1353. doi: 10.1017/S1041610217000734.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1041610217000734</ArticleId><ArticleId IdType="pubmed">28511735</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrera E., Jr., Caramelli P., Silveira A.S., Nitrini R. Epidemiologic survey of dementia in a community-dwelling Brazilian population. Alzheimer Dis. Assoc. Disord. 2002;16:103&#x2013;108. doi: 10.1097/00002093-200204000-00007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00002093-200204000-00007</ArticleId><ArticleId IdType="pubmed">12040305</ArticleId></ArticleIdList></Reference><Reference><Citation>Brucki S.M.D., Nitrini R., Caramelli P., Bertolucci P.H.F., Okamoto I.H. Sugest&#xf5;es para o uso do mini-exame do estado mental no Brasil. Arq. Neuropsiquiatr. 2003;61:777&#x2013;781. doi: 10.1590/S0004-282X2003000500014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/S0004-282X2003000500014</ArticleId><ArticleId IdType="pubmed">14595482</ArticleId></ArticleIdList></Reference><Reference><Citation>Dutra M.C. Master&#x2019;s Thesis. Universidade Cat&#xf3;lica de Bras&#xed;lia; Bras&#xed;lia, Brazil: 2014. Valida&#xe7;&#xe3;o do Question&#xe1;rio de Pfeffer para Popula&#xe7;&#xe3;o Idosa Brasileira.</Citation></Reference><Reference><Citation>Almeida O.P., Almeida S.A. Confiabilidade da vers&#xe3;o brasileira da Escala de Depress&#xe3;o em Geriatria (GDS) vers&#xe3;o reduzida. Arq. Neuropsiquiatr. 1999;57:421&#x2013;426. doi: 10.1590/S0004-282X1999000300013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/S0004-282X1999000300013</ArticleId><ArticleId IdType="pubmed">10450349</ArticleId></ArticleIdList></Reference><Reference><Citation>Koch W., Ehrenhaft A., Griesser K., Pfeufer A., M&#xfc;ller J., Sch&#xf6;mig A., Kastrati A. TaqMan systems for genotyping of disease-related polymorphisms present in the gene encoding apolipoprotein E. Clin. Chem. Lab. Med. (CCLM) 2002;40 doi: 10.1515/cclm.2002.197.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/cclm.2002.197</ArticleId><ArticleId IdType="pubmed">12521230</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>